School of Nursing, University of Victoria, Victoria, British Columbia, Canada.
J Adv Nurs. 2011 Dec;67(12):2732-40. doi: 10.1111/j.1365-2648.2011.05711.x. Epub 2011 Jun 1.
This article presents a discussion of the use of palliative sedation in response to intractable (not responsive to treatment) existential suffering.
Patients suffering from a terminal illness are often faced with severe symptoms at the end of life. Although palliative sedation is sometimes used when no other options are effective in relieving unbearable pain or suffering, its use in response to intractable existential suffering in terminal illness remains controversial.
A literature search was conducted for published articles addressing the use of palliative sedation between 1996 and 2009 using established databases.
Palliative sedation remains an uneasy practice. The debates have centred on ethical issues surrounding decisions to use sedation and on separating the intent of palliative sedation (relief of intolerable symptoms) from the intent of euthanasia (hastening death). There is lack of consensus in defining existential suffering. Consequently, there is limited understanding of how decisions are being made when using palliative sedation to treat intractable existential suffering.
Given the confusion and uncertainty about ethical and clinical justifications for palliative sedation in treating existential suffering, we argue that a better understanding of the controversies and decision-making process is needed. Greater understanding is required to prevent palliative sedation from becoming a substitute for intensive treatment of this kind of suffering.
本文探讨了针对无法缓解的(无法对治疗产生反应的)存在性痛苦使用姑息性镇静的问题。
患有终末期疾病的患者在生命末期经常会面临严重的症状。虽然姑息性镇静有时用于缓解无法忍受的疼痛或痛苦时其他方法无效,但在终末期疾病中针对无法缓解的存在性痛苦使用姑息性镇静仍存在争议。
使用已建立的数据库,对 1996 年至 2009 年期间发表的有关姑息性镇静使用的文章进行了文献检索。
姑息性镇静仍然是一种令人不安的做法。争议的焦点集中在使用镇静的决定所涉及的伦理问题上,以及将姑息性镇静的意图(缓解无法忍受的症状)与安乐死的意图(加速死亡)分开。在定义存在性痛苦方面缺乏共识。因此,对于使用姑息性镇静治疗无法缓解的存在性痛苦时如何做出决策,了解有限。
鉴于在治疗存在性痛苦时使用姑息性镇静的伦理和临床理由存在混淆和不确定性,我们认为需要更好地理解这些争议和决策过程。需要更多的了解,以防止姑息性镇静成为这种痛苦的强化治疗的替代品。